NCT03530059 (FTR) is a clinical trial of Home-based rehabilitation in Respiratory Disease, sponsored by University Hospital, Grenoble.

Who is sponsoring NCT03530059?

NCT03530059 is sponsored by University Hospital, Grenoble.

What drugs are being tested in NCT03530059?

Interventions in NCT03530059: Home-based rehabilitation.

What condition does NCT03530059 study?

NCT03530059 studies Respiratory Disease, Thoracic Surgery, Lung Cancer.

Is NCT03530059 still recruiting?

NCT03530059 is currently completed. Last updated 15 November 2019.

Last reviewed 2019-11-15 · How we verify

NCT03530059: FTR

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Fast-Track Rehabilitation

Completed Last updated 15 November 2019

What this trial tests

trial testing Home-based rehabilitation in Respiratory Disease in 50 participants. Completed in 21 July 2019.

Timeline

9 February 2018

Primary endpoint
21 June 2019

21 July 2019

Quick facts

Lead sponsor	University Hospital, Grenoble
Status	Completed
Study type	OBSERVATIONAL
Enrollment	50
Start date	9 February 2018
Primary completion	21 June 2019
Estimated completion	21 July 2019
Sites	5 locations across France

Drugs / interventions tested

Home-based rehabilitation

Conditions studied

Respiratory Disease — all drugs for Respiratory Disease →
Thoracic Surgery — all drugs for Thoracic Surgery →
Lung Cancer — all drugs for Lung Cancer →

Sponsor

University Hospital, Grenoble

Who can join

18 and older, any sex, with Respiratory Disease or Thoracic Surgery. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study is a prospective observational study which aim to evaluate the feasibility of a total and systematic home respiratory rehabilitation training program in patients who will undergo thoracic surgery, and otherwise tend to define failure reasons.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

What are the barriers to the completion of a home-based rehabilitation programme for patients awaiting surgery for lung cancer: a prospective observational study.
Catho H, Guigard S, Toffart AC, Frey G, et al · · 2021 · cited 7× · PMID 33568371 · DOI 10.1136/bmjopen-2020-041907

Verify or expand the search:

Other trials of Home-based rehabilitation

Trials testing the same drug.

NCT03533088 — Comparing Two Different Rehabilitation Protochols on Patients With Rotator Cuff Repair · NA · completed
NCT02715245 — Multiple Chronic Diseases: the RITH Trial · NA · completed

Other recruiting trials for Respiratory Disease

Currently open trials in the same condition.

NCT06716502 — A New Portable Device for Non-invasive Ventilatory Support · NA · recruiting
NCT06455033 — Manual Diaphragm Release on Stepping Reaction Time in Chronic Obstructive Pulmonary Disease · NA · active not recruiting
NCT06796894 — Symptoms, Respiratory Dysfunction and Frailty Level in Allergic and Eosonophilic Asthmatics · recruiting
NCT06503913 — Cognitive Muscular Therapy for Patients With Long-COVID and Breathing Pattern Disorder · NA · active not recruiting
NCT06569940 — Sleepiz One+ vs. Capnography and Electrocardiography · NA · recruiting

Other University Hospital, Grenoble trials

Trials by the same sponsor.

NCT07479225 — Circulating Cell-Free DNA for Brain Abscess Diagnosis: A Pilot Study · NA · not yet recruiting
NCT07477613 — Implantable Brain-Computer Interface for Upper-Limb Recovery After Stroke · NA · not yet recruiting
NCT07379372 — Bladder Overactivity and Post-Botulinum Toxin Telemonitoring · NA · not yet recruiting
NCT07166991 — Anesthesia sTrategy foR Organ Procurement In braiN dEath · Phase 3 · recruiting
NCT07367880 — The Monument Test : A New Tool for Assessing the Ability to Name and Identify Unique Entities. (TeDIMO) · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03530059 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University Hospital, Grenoble
Last refreshed: 15 November 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03530059.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing